Hormel names ex-Tyson executive as new CFO

Hormel Foods (HRL) appointed Ash Bhumbla, former Tyson Foods executive, as CFO, effective September. Bhumbla succeeds interim CFO Paul Kuehneman, who will remain a senior leader. Hormel recently named John Ghingo as CEO and reported strong Q2 results, with Q3 earnings due Thursday.

Hormel Foods named President John Ghingo as CEO, replacing Jeff Ettinger, effective 26 October. Ettinger will remain on the board. The change follows Ettinger’s interim appointment last year and prior leadership shifts. In June, Hormel guided 2026 sales revenue to $12.2bn-$12.5bn and oversaw asset sales including whole-bird turkey to Life-Science Innovations and Brazil business to Zanchetta Alimentos.

Hormel Foods named insider John Ghingo as CEO, effective Oct. 26, succeeding interim executive Jeffrey Ettinger. Ghingo has led as president and board member since July 2025 and previously ran Hormel’s retail business. The company said it aims to drive growth and modernize operations; it beat Q2 estimates in May and cited resilient demand, especially protein.

Hormel Foods (HRL) agreed to sell its Brazilian Ceratti operations to Zanchetta Alimentos LTDA, with terms undisclosed. Hormel said the divestiture simplifies its portfolio and targets markets with stronger growth. The deal is expected to close in coming weeks, subject to approvals, and is expected to have minimal impact on adjusted fiscal 2026 results.

Hormel reported Q2 progress on its Transform & Modernize (T&M) program, citing improved turkey manufacturing performance, lower Retail selling, general and administrative expenses, and a favorable product mix. The Jennie-O whole-bird turkey sale closed this quarter, causing a $61 million GAAP loss excluded from adjusted results. Hormel kept FY net sales guidance at $12.2–$12.5B and adjusted EPS at $1.43–$1.51, while GAAP EPS guidance fell to $1.28–$1.37.

On May 29, Stephens raised its price objective for Hormel Foods (HRL) to $25 from $22 but kept an Equal Weight rating, citing a Q2 adjusted EPS beat without guidance increases or clearer second-half execution. On the same day, BofA lifted its price target to $25 from $23 and maintained Neutral, saying the stock’s reaction reflected relief and that execution confidence is improving.